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Abstract 
The extent of methicillin-resistant Staphylococcus aureus (MRSA) in children is still unknown. The 
collected wound pus samples were processed. Identification of S. aureus was done according to 
standard microbiological procedures as per the clinical laboratory standards institute (CLSI) 
guidelines (2016). The antibiogram of the isolates was carried out by the Kirby-Bauer disc 
diffusion technique. MRSA was determined by measuring the zone of inhibition (ZOI) 
surrounding to cefoxitin disc, with resistance defined as ZOI of ≤ 21 mm. Out of 357 bacterial 
culture-positive samples, 278 (77.87 %) were S. aureus isolates, among them 102 (36.69%) were 
found to be MRSA. The percentage of MRSA isolates was found high in male children and 
inpatients with 61.76 % and 73.52% respectively. All the MRSA isolates were susceptible to 
gentamicin (79.41%), whereas (91.17%) were resistant to penicillin. The distribution of MRSA in 
inpatients 75 (73.52%) is higher than that of outpatients 27 (26.74%). This study shows that the 
MRSA occurrence is prevalent in pediatric patients. 
Keywords: Staphylococcus aureus, MRSA, Antibiotic susceptibility test, Disc-diffusion, Methicillin 
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Introduction 
Staphylococcus aureus (S. aureus) is one of the 
important human pathogen known over the past 
several decades. It is the cause of hospital and 
community-acquired infections [1]. It is one of 
the versatile nosocomial pathogens worldwide 
causing skin infections to life-threatening 
systemic illnesses including pneumonia, 
osteomyelitis and endocarditis [2, 3]. S. aureus is 
one of the common and important Gram-positive 
hospital-acquired organisms. It can cause 
infection; most commonly at sites of lowered host 
resistance such as damaged skin or mucosal 
membranes, infections like pimples, boils and 
abscesses to severe systemic infections like 
bacteremia, endocarditis, pneumonia and toxic 
shock syndrome [4, 5]. 
S. aureus resistant to oxacillin, methicillin and a 
few others related antibiotics are all known under 
the generic term methicillin-resistant S. aureus. 
The penicillin-resistance S. aureus (PRSA) is 
typically coincides with the emergence of MRSA 
[6]. MRSA is a global public health problem, 
associated with considerable morbidity and 
mortality, causing both hospital and community-
acquired infections [7]. Among the many species 
of antibiotic-resistant bacteria, MRSA is one of 
the most important causes of antibiotic treatment 
failure, increased morbidity and mortality. S. 
aureus has a remarkable ability to colonize the 
skin and mucous membranes. Hospitalized 
patients and health-care workers have higher 
colonization rates than the general population 
[8]. Studies revealed that nearly 6% hospital 
personnel and nearly 3% outpatients carry MRSA 
[9-12]. 
The prevalence of MRSA has varied from 
hospital to hospital in various countries. Several 
types of research and studies conducted in Nepal 
about S. aureus and their antibiotic susceptibility 
pattern suggest the gradual emergence of MRSA 
in hospitals. However, only a few reports related 
to MRSA are available in Nepal which is carried 
out in different hospitals at different periods. In a 
bacteriological study carried out at Tribhuvan 
University Teaching Hospital (TUTH), the 
prevalence of MRSA was found to be 23.5% [13]. 
A similar study carried out at Kanti Children’s 
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Hospital showed 31.4% of MRSA isolates and 
11.7% from TUTH [14]. Rajbhandari et al. (2002) 
reported 54.9% strains of MRSA [15]. Similarly, 
Kumari et al. (2008) reported 26.14% MRSA 
strains in a study carried out in a tertiary- care 
hospital in Eastern Nepal [16]. Sanjana et al. 
(2010) also reported 39.6% Methicillin-resistant S. 
aureus isolates at the College of Medical Sciences-
Teaching Hospital, Chitwan. Tiwari et al. (2009) 
reported MRSA isolates were resistant to co- 
trimoxazole was 77% and 81.7% (Ansari et al. 
2014). Pant et al. (2018) reported 82.6% MRSA 
resistance to chloramphenicol [17-20]. 
The prime focus of the study is the distribution 
and prevalence of S. aureus and MRSA in wound 
samples collected in the microbiology laboratory 
of International Friendship Children’s Hospital 
as well as on its antibiotic sensitivity pattern. The 
study will also demonstrate the present scenario 
of MRSA in children and the sensitivity pattern 
of different antibiotics used against it. This is 
useful for future planning and policy making in   
health care centers and hospitals in order to 
combat the spreading of infectious diseases. 
Materials and Methods 
Sample collection and transportation 
Clinical specimens were collected, stored, 
transported and processed in the laboratory 
immediately after collection by following 
standard microbiology guidelines [21]. The 
sterile swab was moved across the surface of 
wounds in a zigzag motion and pus aspirates 
were collected aseptically by puncturing the 
wound using a sterile syringe. The accurate, 
rapid microbiological diagnosis of MRSA and S. 
aureus infections begins with proper specimen 
collection and rapid transportation to the 
laboratory. To make sure the collection of the best 
possible specimen, the Health Care Workers 
(HCWs) must be properly trained, and the 
patient must be provided with clearly presented 
and fully understood instruction for sample 
collection. 
Specimen processing 
Pus samples received in the microbiology 
laboratory were processed as per routine 
standard microbiological procedures described 
by the established guideline for the isolation and 
identification of S. aureus [22]. 
Culture of specimen 
All the pus samples were inoculated on blood 
agar (BA) and Mac-conkey agar (MA) plates and 
incubated aerobically at 37 ̊ C for 24 to 48 hours 
in the incubator. If no growth was observed, it 
was reported as growth negative. The suspected 
S. aureus isolates (on the basis of haemolysis 
produced on BA) were inoculated in to mannitol 
salt agar (MSA) to check if the isolates ferment 
mannitol or not. Photograph of S. aureus culture 
on blood agar and MSA is pictured in figure 1. 
 
Figure 1. Photograph of S. aureus culture on (A) 
blood agar (B) mannitol salt agar (MSA) 
 
Figure 2. Photograph of antibiotic sensitivity test 
of S. aureus on MHA. A: Gentamicin (30mcg), B: 
Chloramphenicol (30mcg), C: Cefoxitin (30mcg), 
 D: Ciprofloxacin (5mcg), E: Penicillin (10mcg)
B 
A 
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Figure 3. Flow chart representing isolation and identification of MRSA from pus samples 
Identification of the isolates 
The growth was identified as S. aureus by using 
conventional biochemical methods as per 
standard microbiological techniques described in 
Bergey's Manual of Determinative Bacteriology 
[23]. It comprises colonial morphology, staining 
reactions and various biochemical properties 
such as catalase-positive, coxidase negative, 
fermentative, Voges-Proskauer positive, etc.  
Preservation of isolates 
Isolates in pure culture were preserved in 
glycerol 20% (v/v) in brain heart infusion broth 
(BHI) at –20 ̊ C to -70 ̊ C and recovered by sub 
culturing in brain heart infusion broth at 37 ̊ C for 
24 hrs followed by further subculture on nutrient 
agar. 
Antimicrobial susceptibility testing of 
S. aureus 
Antibiotic susceptibility testing of isolates was 
assessed by the modified Kirby-Bauer disk 
diffusion method as recommended by the 
Clinical and Laboratory Standard Institute using 
Mueller Hinton Agar (MHA) [22]. Using a sterile 
wire loop, a single isolated colony of which the 
sensitivity pattern is to be determined was 
touched and inoculated into a nutrient broth 
(NB) tube and was incubated for 2-4 hours. After 
incubation in a good light source, the turbidity of 
the suspension was matched with the turbidity of 
the standard of Mac Farland 0.5 (Prepared by 
adding 0.6mL of 1% w/v barium chloride 
solution to 99.4mL of 1% v/v solution of 
sulphuric acid) [24]. Using a sterile swab, a plate 
of Mueller Hinton agar was inoculated with 
bacterial suspension using carpet culture 
technique and plates were taken for incubation at 
37 ̊ C for 18-24 hours. The result was interpreted 
as whether the organism was sensitive or 
resistant to the tested antimicrobial agents. 
Photograph of antibiotic sensitivity test of S. 
aureus on MHA is shown in figure 2.  
Detection of MRSA 
MRSA detection was done by the cefoxitin disc 
(30µg) diffusion test. As per CLSI (2015) 
guideline, a lawn culture was made on Mueller 
Hinton Agar (MHA) supplemented with 4% 
NaCl and cefoxitin disc from the suspension of 
turbidity equivalent to 0.5 Mc Farland standards 
from overnight growth in nutrient agar and 
incubated for 24 hours aerobically at 35 ̊ C. After 
incubation, the plates were examined for zone of 
inhibition. Isolates exhibiting zone of inhibition ≥ 
22 mm were considered as sensitive, whereas 
those showing zone of inhibition ≤ 21 mm were 
considered as resistant and were reported as 
MRSA.  
Purity plate 
The purity was used to ensure that the 
inoculation used for the biochemical  tests  was.  
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Table 2. Gender wise distribution of patients 
(P > 0.05) 
 Male Female Total 
Culture 
positive 
196(54.9) 161(45.09) 357(54.9) 
Culture 
negative 
162 (45.2) 131 (44.8) 293(45.1) 
Total 358 (55.1) 292 (44.9) 650 (100) 
 
pure culture and also to see whether the 
biochemical tests were performed in aseptic 
condition or not. Thus, while performing 
biochemical tests, in biochemical media, the same 
inoculum was sub-cultured on one half of 
Nutrient Agar (NA) medium before (pre purity) 
inoculation and another half after (post purity) 
inoculation. The maintenance of aseptic 
condition is indicated by the growth of the same 
organism in pure form in both pre and post 
halves of the medium. The Chart below 
represents the isolation and identification of 
MRSA from pus samples. 
All the raw data collected in the microbiology 
laboratory were statistically analyzed by using 
computer-based software program SPSS version 
20. The flow chart representing isolation and 
identification of MRSA from pus samples is 
shown in figure 3. 
Results and Discussion 
 Bacterial growth in different pus samples 
and gender wise distribution of patients 
Out of 650 total samples, 550 samples were pus 
swab and 100 samples were pus aspirate. Among 
total pus swabs 303 (55.09%) were culture 
positive and 247 (44.91%) showed no growth. 
Moreover, among total pus aspirates, 54 (54%) 
were culture positive and the remaining 46 (46%) 
showed no growth as shown in Table 1. 
Out of total cases, 358 (55.07%) were male 
patients and 292 (44.92%) were female patients. 
The growth was found to be higher in male 
patients 196 (54.9%) than in female patients161 
(45.09%). The association between gender and 
growth of bacteria was not statistically significant 
(p-value > 0.05) is presented in Table 2. 
Among 650 pus samples, the majority i.e. 352 
(54.15%) were In-patients who were admitted to 
the different departments in the hospital and 298 
(45.23%) were from OPD. A total 221 (62.78%) of 
In- Patient Department (IPD) and 136 (45.36 %) of 
Out Patient Department (OPD) showed growth. 
Such distribution pattern of growth on the basis 
of the department was statistically significant (p-
value <0.05) is as in table 3. 
Distribution of S. aureus in pus sample 
Among the culture-positive specimens, 278 
(77.87%) S. aureus isolates were obtained while 
remaining 79 (22.12 %) were other bacterial 
isolates which include both gram-positive 
Coagulase Negative Staphylococcus species (CoNS) 
and gram-negative bacteria (E. coli, Pseudomonas 
aeruginosa, Klebsiella pneumonia and Enterobacter 
aerogens) as shown in pie chart in figure 4. 
Distribution of clinical isolates of S. 
aureus according to age and gender of 
the patient 
Among 278 S. aureus isolates, a higher number of 
isolation was found in male 169 (60.79%) as 
compared to female 109 (39.20%) patients. In the 
male, the maximum number of S. aureus isolates 
(n=87, 51.47 %) was observed in the patient with 
an age group of 1-5 and in females, the maximum 
Table 1. Bacterial growth in different pus samples 
Types of 
sample 
Growth 
(No. %) 
No growth 
(No. %) 
Total 
Pus 
swab 
303(55.09%) 247(44.91%) 550 
Pus 
aspirate 
54 (54%) 46 (46%) 100 
Total 357 (54.92) 293 (45.08) 650(100) 
Table 3. Distribution of bacterial growth on the basis of hospital Department 
Organism IPD {n (%)} OPD {n (%)} Total {n (%)} p-value 
Culture 
positive 
221 (62.78) 136 (45.36) 357 (54.92)  
Culture 
negative 
131 (37.21) 162 (54.36) 293 (45.07) P < 0.05 
Total 352 (54.15) 298 (45.84) 650 (100)  
Nepal Journal of Biotechnology. Dec .  2019  Vol. 7, No. 1: 82-89                 Bhandari et al. 2019 
 
©NJB, Biotechnology Society of Nepal  86 Nepjol.info/index.php/njb. 
 
 
 
Figure 4. Distribution of S. aureus in pus sample. 
number of S. aureus isolates (n=55, 50.45 %) was 
observed in the same 1-5 age group patients. 
Likewise, the least number of S. aureus isolates 
(n=12, 7.10%) was observed in 11-15 age group 
patient in male and female least number of S. 
aureus isolates (n=9, 8.25 %) was observed in the 
same 11-15 age group patients is shown in Table 
4. 
Table 4. Distribution of clinical isolates of S. 
aureus according to age and gender of the patient 
Age 
group(in 
years) 
Gender Total 
Male Female No. % 
Below 1 
1-5 
6-10 
11-15 
32 
87 
38 
12 
18 
55 
27 
9 
50 
142 
65 
21 
17.98 
51.07 
23.38 
7.55 
Total 169(60.79%) 109(39.2%) 278 100.0 
Comparison of clinical isolates of S. 
aureus in inpatients and outpatients 
Among 278 S. aureus isolates, 177 (63.66 %) 
isolates of S. aureus were from inpatients whereas 
101 (36.33%) S. aureus were from outpatients. 
Similarly, among 79 growths other than S. aureus 
isolates, 47 (59.49 %) and 32 (40.50%) cases of 
cultures other than S. aureus were found from 
inpatients and outpatients respectively. A 
comparison of clinical isolates of S. aureus in 
inpatients and outpatients is pictured in figure 5. 
Distribution of MRSA among S. aureus and 
in different age groups 
Out of 357 culture-positive isolates, 278 (77.87 %) 
were S. aureus. Out of total S. aureus; 102 (36.69%) 
were MRSA and 176 (63.30 %) were MSSA 
(Methicillin-sensitive Staphylococcus aureus).  Out 
of 169 (60.79%) S. aureus isolates among male 
patients, 63 (61.76%) were found to be MRSA. 
Likewise, among 109 (39.20 %) S. aureus isolates 
among female patients, 39 (38.23 %) were found 
to be MRSA. Such distribution of MRSA based on 
gender was not statistically significant (p-value; 
> 0.05) is given in the pie chart in figure 6. 
 
Figure 5. Comparison of clinical isolates of S. 
aureus in inpatients and outpatients 
 
Figure 6. Distribution of MRSA among S. aureus 
Out of 278 S. aureus isolates, altogether 102 
(36.69%) and 176 (63.30%) were identified as 
MRSA and MSSA respectively by cefoxitin disc 
diffusion test which constituted 75 (73.52%) 
MRSA and 101 (57.38%) MSSA in admitted 
patients. Similarly, in outpatients, 27(26.47%) 
MRSA and 75(42.61%) MSSA were observed. The 
association in the MRSA occurrence and 
inpatients was statistically significant (p = 0.024) 
is in Table 5
77.87%
22.12%
S. aureus
Others
59.49%
40.50 %
63.66%
36.33%
0
20
40
60
80
100
120
140
Inpatient Outpatient
Others
S. aureus
63.30 
%
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Table 5. Distribution of MRSA in outpatients and inpatients 
 Inpatients (No. %) Outpatients (No. %) Total (No. %) P-value 
MRSA 
MSSA 
75(73.52%) 
101 (57.38%) 
27 (26.47%) 
75 (42.61 %) 
102 (36.69%) 
176 (63.30%) 
 
P < 0.05 
Total 176 102 278 (100.0)  
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Antibiotic susceptibility pattern of S. 
aureus isolates 
The antibiotic susceptibility pattern showed that 
the highest number of isolates were resistant to 
penicillin (n=250, 89.92%), ciprofloxacin (n=178, 
64.02%), ofloxacin (n=162, 58.27%), 
cotrimoxazole (n=153, 55.04%), erythromycin 
(n=112, 40.28%), cefoxitin (n=102, 36.69%) and 
cloxacillin (n=98, 35.25%). The highest number of 
penicillin resistant S. aureus developed the 
ability to inactivate the β- lactam ring of penicillin 
by producing plasmid encoded β- lactamase [25]. 
Similarly, highest number of MRSA isolates were 
susceptible to gentamicin (n=264, 94.96%) is due 
to the combination β- lactam and amino 
glycosides which increases bacterial killing in-
vitro and in animal model of endocarditis, 
followed by chloramphenicol (n=255, 91.72%), 
cefotaxime (n=236, 84.89%) and amikacin (n=236, 
84.89%), cloxacillin (n=180, 64.74%), cefoxitin 
(n=176, 63.30%), erythromycin (n=166, 
59.7%) is as shown in table 6. 
 
Antibiotic susceptibility pattern of 
MRSA and MSSA isolates 
The isolates of S. aureus were broadly 
categorized into two groups: MRSA and 
MSSA. Both the groups of S. aureus showed 
marked variation in the sensitivity pattern 
against common antibiotics. 
It was observed that, for MRSA, the most 
effective antibiotic was cefotaxime (n=83, 
81.37%) followed by gentamicin (n=81, 
79.41%), amikacin (n=77, 75.49%), 
chloramphenicol (n=76, 74.50%). Similarly, 
highest resistance of MRSA was with penicillin 
(n=93, 91.17%) followed by ciprofloxacin (n=85, 
83.3%) and cotrimoxazole (n=77, 75.49%) is in 
table 7. 
Conclusion 
MRSA has acquired resistant to previously 
effective antimicrobials including in the 
penicillin, methicillin in comparison over the past 
50 years. In hospital infected patients and health 
carriers are also important source of nosocomial 
S. aureus [26, 27]. Out of 278 S. aureus isolates 
isolated from pus samples, 102 (36.69%) were 
methicillin-resistant (MRSA). From this study it 
can be concluded that MRSA infection in 
pediatric patients is still one of the most 
threatening infections in hospitals of Nepal. The 
rate of MRSA occurrence was found to be higher 
in inpatients compared to outpatients and the 
male patient than female patients. The highest 
number of MRSA isolates was found in 1-5 age 
Table 6. Antibiotic susceptibility pattern of S. aureus 
isolates 
Antibiotics 
Used 
Total No of S. aureus isolates =278 
Sensitive % Resistant % 
Amikacin 
Ciprofloxacin 
Cotrimoxazole 
Cefoxitin 
Erythromycin 
Cloxacillin 
Cefotaxime 
Penicillin 
Ofloxacin 
Chloramphenicol 
Gentamicin 
236 
100 
125 
176 
166 
180 
236 
28 
116 
255 
264 
84.89 
35.97 
44.96 
63.30 
59.7 
64.74 
84.89 
10.08 
41.72 
91.72 
94.96 
42 
178 
153 
102 
112 
98 
42 
250 
162 
23 
14 
15.10 
64.02 
55.04 
36.69 
40.28 
35.25 
15.10 
89.92 
58.27 
8.27 
5.03 
Table 7. Antibiotic susceptibility pattern of MRSA and MSSA isolates 
Antibiotics 
Used 
MSSA(n=176) MRSA(n=102) 
Sensitive % Resistant % Sensitive % Resistant % 
Amikacin 163 92.61 13 7.38 77 75.49 25 24.50 
Ciprofloxacin 91 51.70 85 48.29 17 16.60 85 83.33 
Cotrimoxazole 93 52.84 83 47.15 25 24.5 77 75.49 
Cefoxitin 176 100.0 0 0.0 0 0.0 102 100.0 
Erythromycin 114 64.77 62 35.22 59 57.84 43 42.15 
Cloxacillin 151 85.79 25 14.20 76 74.50 26 25.49 
Cefotaxime 161 91.47 15 8.52 83 81.37 19 18.62 
Penicillin 35 19.88 141 80.11 9 8.82 93 91.17 
Ofloxacin 88 50.00 88 50.00 26 25.49 76 74.50 
Chloramphenicol 165 93.75 11 6.25 76 74.50 26 25.49 
Gentamicin 167 94.88 9 5.11 81 79.41 21 20.59 
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group patients. The most effective antibiotic 
against MRSA in pediatric patients was found to 
be gentamicin. Similarly, chloramphenicol, 
cefotaxime were also found to be effective against 
MRSA infections whereas penicillin was found to 
be the least effective antibiotic to treat MRSA 
infections where 89.92 % of S. aureus isolates 
showed resistance towards this antibiotic. 
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